Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05464940 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction

StatusNot Yet Recruiting
PhaseNot applicable
Started2025-09
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 28, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
This "How caffeine Induces Atrial Tachyarrhythmias" trial will be a multi-center, randomized, double-blinded trial of intravenous caffeine versus placebo among patients undergoing pulmonary vein isolation procedures for Atrial Fibrillation(AF).

Amendment record

Amended 5 times since 2022-07-15; most recent filed 2025-08-27. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2025-08-27
Amendment Study Status v5
2024-10-23
Amendment Study Status v4
2023-03-08
Amendment Study Status v3
2022-11-15
Amendment Study Status v2
2022-07-18
Amendment Study Status, Study Description, Arms and Interventions, Outcome Measures v1
2022-07-15
Original filing
Trial Details
NCT Number NCT05464940
Lead Sponsor Kansas City Heart Rhythm Research Foundation
Collaborators: Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Austin, TX, USA, Loma Linda University
Conditions Atrial Fibrillation
Enrollment 100 participants
Start Date 2025-09
Primary Completion 2026-03 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-28